EX-FILING FEES 2 d502458dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables(1)

Form S-3

(Form Type)

Pfizer Inc.

Pfizer Investment Enterprises Pte. Ltd.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security

Type

 

Security

Class

Title

 

Fee

Calculation
Rule

 

Amount

Registered

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

 
Newly Registered Securities
                 

Fees to Be

Paid

  Debt   4.650% Notes due 2025   457(r)   $3,000,000,000   99.943%   $2,998,290,000   0.0001102   $330,412
                 

Fees to Be

Paid

  Debt   4.450% Notes due 2026   457(r)   $3,000,000,000   99.883%   $2,996,490,000   0.0001102   $330,214
                 

Fees to Be

Paid

  Debt   4.450% Notes due 2028   457(r)   $4,000,000,000   99.880%   $3,995,200,000   0.0001102   $440,272
                 

Fees to Be

Paid

  Debt   4.650% Notes due 2030   457(r)   $3,000,000,000   99.823%   $2,994,690,000   0.0001102   $330,015
                 

Fees to Be

Paid

  Debt   4.750% Notes due 2033   457(r)   $5,000,000,000   99.850%   $4,992,500,000   0.0001102   $550,174
                 

Fees to Be

Paid

  Debt   5.110% Notes due 2043   457(r)   $3,000,000,000   98.000%   $2,940,000,000   0.0001102   $323,988
                 

Fees to Be

Paid

  Debt   5.300% Notes due 2053   457(r)   $6,000,000,000   99.851%   $5,991,060,000   0.0001102   $660,215
                 

Fees to Be

Paid

  Debt   5.340% Notes due 2063   457(r)   $4,000,000,000   98.057%   $3,922,280,000   0.0001102   $432,236
                 
    Other   Guarantees of Pfizer Inc.   457(n)   N/A   N/A   N/A   N/A   N/A(2)
                 
Total               $31,000,000,000       $30,830,510,000       $3,397,526

 

(1)

The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offering.

(2)

Pfizer Inc. will fully and unconditionally guarantee the notes issued by Pfizer Investment Enterprises Pte. Ltd. Pursuant to Rule 457(n) under the Securities Act of 1933, as amended, no separate filing fee is required for the guarantees.